Clinical Trials Browser

Phase 2 × Leukemia, Lymphocytic, Chronic, B-Cell × beta-Glucans × Clear all

NCT00290407 2018-05-04

Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)

Phase 2 Terminated

2 enrolled 2 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell